Nicole Mayer-Hamblett

Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa

Lisa Saiman, Bruce C. Marshall, Nicole Mayer-Hamblett et al. · JAMA · 2003 · 956 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation

Frank J. Accurso, Steven M. Rowe, John P. Clancy et al. · New England Journal of Medicine · 2010 · 802 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis

Steven M. Rowe, Sonya L. Heltshe, Tanja Gonska et al. · American Journal of Respiratory and Critical Care Medicine · 2014 · 498 citations

Medicine, Pharmacology, Pharmacotherapy +17

Susceptibility Testing of Pseudomonas aeruginosa Isolates and Clinical Response to Parenteral Antibiotic Administration

Arnold L. Smith, Stanley B. Fiel, Nicole Mayer-Hamblett et al. · CHEST Journal · 2003 · 308 citations

Life Sciences, Infectious Diseases, Microbiology +14

LasR Variant Cystic Fibrosis Isolates Reveal an Adaptable Quorum-Sensing Hierarchy in Pseudomonas aeruginosa

John Feltner, Daniel J. Wolter, Christopher E. Pope et al. · mBio · 2016 · 301 citations · Full text

Life Sciences, Genetics, Microbiology +17